(Date:11/30/2009)... , CHANGCHUN, China and LOS ANGELES, Nov. 3...rmaceuticals, Inc. (OTC Bulletin Board: CYXN; ,Chi...eading manufacturer, distributor and,retailer of p...ced it has,completed preparation for distribution ... The Chinese government recently formalized the n...
(Date:11/30/2009)... , SEATTLE, Nov. 30 /PRNewswire-FirstCall/ -...TIC) announced today that its new class of platinu...s, demonstrated a stronger anti-tumor potency and ...based compounds as well as the ability to overcome...esults were presented in a paper titled "Novel Bis...
(Date:11/30/2009)... , AMSTERDAM, Novembe...,s,leading publisher of scientific, medical and te...ajor re-launch of Embase, its comprehensive biomed...records from more than 7,000,active, peer reviewed... role in the advancement of new biomedical,and pha...
(Date:11/27/2009)..., PARIS, November 27 /PRNewswire-FirstCall/ -...to market Oralair(R) in both adults and children,t...e first country where,Oralair(R) has been marketed...ir(R) is now registered in Austria, Belgium, Bulga...Germany, Greece, Hungary, Ireland, Italy,Latvia, ...
Breaking Biology Technology:China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3